Neonatal jaundice: phototherapy

Paul Woodgate1, Luke Anthony Jardine

  • 1Department of Neonatology, Mater Mothers' Hospital, Brisbane, Australia.

Insights

This systematic review examines hospital phototherapy for newborn jaundice. It analyzes various light wavelengths, intensities, doses, and treatment start times to determine optimal effectiveness and safety in term and preterm infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Phototherapy Research
  • Evidence-Based Pediatrics

Background:

  • Neonatal jaundice affects a significant percentage of term (50%) and preterm (80%) infants.
  • Jaundice results from bilirubin deposition, often due to increased red blood cell breakdown or reduced bilirubin excretion.
  • Most cases of newborn jaundice are transient, typically resolving within 1-2 weeks.

Purpose of the Study:

  • To systematically review the effects of different light parameters in hospital phototherapy for unconjugated hyperbilirubinemia in infants.
  • To evaluate the impact of varying light wavelengths, intensities, total doses, and initiation thresholds on treatment outcomes.
  • To assess the safety and effectiveness of phototherapy interventions for neonatal jaundice.

Main Methods:

  • A systematic review was conducted, searching major medical databases including Medline, Embase, and The Cochrane Library.
  • Included studies focused on hospital phototherapy for unconjugated hyperbilirubinemia in term and preterm infants.
  • Data on intervention effectiveness, safety, and harms alerts from regulatory agencies were collected and analyzed.

Main Results:

  • Fourteen studies met the inclusion criteria for the systematic review.
  • The quality of evidence for various phototherapy interventions was evaluated using the GRADE system.
  • Information regarding the effectiveness and safety of different phototherapy parameters was compiled.

Conclusions:

  • The review provides comprehensive information on hospital phototherapy for neonatal jaundice.
  • Findings relate to the effectiveness and safety of varying wavelengths, intensities, total doses, and commencement thresholds.
  • This evidence supports clinical decision-making regarding phototherapy for unconjugated hyperbilirubinemia in newborns.
Abstract

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.2K
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
64
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
352
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
5.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
868
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.9K